15 Nov 2019
LIBERUM: PureTech Health - resTORbio failure trims NAV but over 30% upside remains
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: PureTech Health - resTORbio failure trims NAV but over 30% upside remains
PureTech Health PLC (PRTC:LON) | 208 -3.1 (-0.7%) | Mkt Cap: 561.4m
- Published:
15 Nov 2019 -
Author:
Graham Doyle | Alistair Campbell -
Pages:
2